Effects of susceptibility variants may depend on from which parent they are inherited. Although many associations between sequence variants and human traits have been discovered through genome-wide associations, the impact of parental origin has largely been ignored. Here we show that for 38,167 Icelanders genotyped using single nucleotide polymorphism (SNP) chips, the parental origin of most alleles can be determined. For this we used a combination of genealogy and long-range phasing. We then focused on SNPs that associate with diseases and are within 500 kilobases of known imprinted genes. Seven independent SNP associations were examined. Five-one with breast cancer, one with basal-cell carcinoma and three with type 2 diabetes-have parental-origin-specific associations. These variants are located in two genomic regions, 11p15 and 7q32, each harbouring a cluster of imprinted genes. Furthermore, we observed a novel association between the SNP rs2334499 at 11p15 and type 2 diabetes. Here the allele that confers risk when paternally inherited is protective when maternally transmitted. We identified a differentially methylated CTCF-binding site at 11p15 and demonstrated correlation of rs2334499 with decreased methylation of that site.
The effect of sequence variants on phenotypes may depend on parental origin. The most obvious scheme, although not the only one 1 , is imprinting in which the effect is limited to the allele inherited from a parent of a specific sex. Despite this, most reports of genomewide association studies have treated the paternal and maternal alleles as exchangeable. This is understandable, as the information required is often unavailable, but it reduces the power of such studies to discover some susceptibility variants and underestimates the effects of others, contributing to unexplained heritability. Here we describe a method that allows us to determine the parental origin of haplotypes systematically even when the parents of probands are not genotyped. We use the results to discover associations that exhibit parental-origin-specific effects.
Determining parental origin Long-range phasing allows for accurate phasing of Icelandic samples typed with Illumina BeadChips for regions up to 10 cM in length 2 . Two advances have been made since then, stitching and parentalorigin determination. Genome-wide, long-range phasing was applied to overlapping tiles, each 6 cM in length, with 3-cM overlaps between consecutive tiles. For each tile, we attempted to determine the parental origins of the two phased haplotypes regardless of whether the parents of the proband were chip-typed. Using the Icelandic genealogy database, for each of the two haplotypes of a proband a search was performed to identify, among those individuals also known to carry the same haplotype, the closest relative on each of the paternal and maternal sides (Fig. 1) . Results for the two haplotypes were combined into a robust single-tile score reflecting the relative likelihood of the two possible parental-origin assignments {Lists of participants and affiliations appear at the end of the paper. are two phased haplotypes of a proband. Among other typed individuals, the closest paternal relative known also to carry the blue haplotype is R 1 , a cousin; the corresponding maternal relative is R 2 . For the red haplotype, a maternal aunt (R 3 ) carries the haplotype, and the closest known carrier on the paternal side is R 4 . Because R 1 is a closer relative than R 2 , and R 3 is a closer relative than R 4 , the blue and red haplotypes are probably paternally and maternally inherited, respectively. The single-tile score (Methods) supporting this assignment is 0.194.
(with a score greater than zero supporting one assignment and a score less than zero supporting the other assignment; see Methods for details). We then tried to stitch the haplotypes from consecutive tiles together on the basis of sharing at the overlapping region. Stitching and parental-origin determination are complementary tasks. Specifically, if parental origin is determined with high confidence for one tile, the information can be propagated to other tiles through stitching ( Supplementary Fig. 1a) . Conversely, in cases in which the overlap between two adjacent tiles is homozygous for all SNPs, stitching can still be accomplished if parental origins can be determined for both tiles independently ( Supplementary Fig. 1b ). For haplotypes derived by stitching, a contig score for parental origin is computed by summing the individual single-tile scores.
After filtering based on various quality and yield criteria, 289,658 autosomal markers and 8,411 markers on chromosome X were used. Excluding those with no parent listed in the genealogy database or with a genotyping yield of less than 98%, 38,167 individuals, the majority typed with Illumina HumanHap300 or CNV370 BeadChips (Supplementary Information), were processed. For these individuals, 97.8% of the heterozygous genotypes were long-range phased, and in 99.8% of these the parental origin was determined. Overall, 3,841,331,873 heterozygous genotypes, or 97.7% of all heterozygous genotypes, had parental origin assigned. The data includes 2,879 typed trios. To evaluate the accuracy of our method empirically, a run was performed with the data for parents in these trios removed when determining parental origin. For 231,585,437 heterozygous genotypes in the probands/offspring, parental origin was determined both by our method and using the trio data directly, with 500,330 discrepancies, an error rate of 0.22%. Because the trios tested passed heritability checks in preprocessing, the error rate for individuals with fewer than two parents genotyped is probably higher. Nevertheless, the overall error rate is probably less than 0.4% (Supplementary Information).
Imprinting and disease association Although many mechanisms can lead to parental-origin-specific association with a phenotype, sequence variants located close to imprinted genes are more likely to exhibit such behaviour a priori. Table 2 ). After further restriction to diseases for which genome scans have been published based on Icelandic data, four associations remained. Three other SNP associations we were aware of that fall within the imprinted regions, one recently published for basal-cell carcinoma 7 and two new type 2 diabetes (T2D) variants discovered in the Diabetes Genetics Replication and Meta-analysis (DIAGRAM) sample set (unpublished data, DIAGRAM Consortium; Supplementary Information), were also examined.
Association analysis
For each disease-SNP association, five tests were performed (Table 1) . We performed a standard case-control test without taking parental origin into account to provide a baseline. Then we performed a NCBI build 36 position is shown in terms of chromosome and base number. N, case sample size; M, control set size; F con , control frequency (frequency of the risk allele in controls). * The first allele is the risk allele on the basis of analyses that do not take into account parent of origin. { Imputed allele probabilities were used. { Genomic control was applied (true for all P values shown).
1 The effect of the paternally inherited allele was tested by comparing the corresponding alleles in cases with those in controls. The effect of the maternally inherited allele was tested similarly.
| |The test assumes a multiplicative effect for the paternally and maternally inherited alleles, but allows the effects to be different under the alternative hypothesis when the null hypothesis of no effect is tested. "To test directly whether the paternally and maternally inherited alleles have different effects, their allele frequencies were compared within the cases. Information for this test was mainly captured by the counts of the two types of heterozygote: n12 denotes the number of cases who have inherited allele 1 from the father and allele 2 from the mother, and n21 denotes the number of cases who have inherited allele 2 from the father and allele 1 from the mother.
case-control analysis separately for the paternally and maternally inherited alleles. A 2-d.f. test was applied to evaluate the joint effect. A multiplicative model was assumed for the two alleles, but the magnitude and direction of the effect were allowed to differ. Finally, the difference between the effects of the paternally and maternally inherited alleles was directly tested by comparing their allele frequencies within cases. The information for this test came mainly from the counts of the two types of heterozygote within cases (Supplementary Information). Two of the seven associations examined, one with prostate cancer and another with coronary artery disease, did not exhibit parentalorigin-specific effects (Supplementary Information and Supplementary Table 3 ). The five associations that did are presented here. Breast cancer. Allele C of rs3817198 in the 11p15 region (Fig. 2) was reported 8 to be associated with breast cancer with an allelic odds ratio of OR 5 1.07 (P 5 3 3 10
29
). This study included about 21,860 cases and 22,578 controls, allowing this modest effect to achieve genomewide significance. A study 9 of 9,770 cases and 10,799 controls in the Cancer Genetic Markers of Susceptibility project reported odds ratios of 1.02 and 1.12 for heterozygous and homozygous carriers of the same variant, respectively. Using information in their supplementary material, we deduced a P value of 0.06. Marker rs3817198 is not on the Illumina chips used to type the majority of the Icelandic samples, but is included on the Illumina 1M BeadChips for which we have data on 124 trios. We used a single-track assay to type another 90 trios, giving a total of 214 trios with genotypes for rs3817198, which translates to a training set of 856 haplotypes. Adapting the statistical model used by IMPUTE 10 , allele probabilities of rs3817198 were calculated for individuals with phased and parental-origin-determined haplotypes for this region (Supplementary Information). With the imputation results for 1,803 cases and 34,909 controls (Table 1) , the standard case-control test gave a non-significant odds ratio of 1.04 (P 5 0.36). However, when parental origin was taken into account, the paternally inherited allele showed a significant association (OR 5 1.17, P 5 0.0038). The direct test of parental-origin-specific effects that used only the case data was even more significant (P 5 6.2 3 10 24 ). This is because the estimated effect of allele C when maternally inherited, although not significant (P 5 0.11), is protective (OR 5 0.91). Basal-cell carcinoma. We recently identified association of allele T of rs157935, located at 7q32 (Fig. 3) , with basal-cell carcinoma (OR 5 1.23, P 5 5.7 3 10 210 ) 7 . Limiting the analysis to samples for which parental origin could be determined, the paternally inherited allele was significantly associated with the disease (OR 5 1.40, P 5 1.5 3 10 26 ), but the effect of the maternally inherited allele, although it was in the same direction, was not significant (OR 5 1.09, P 5 0.19; Table 1 ). Tested directly, the effects of the paternally and maternally inherited alleles were significantly different (P 5 0.01). Type 2 diabetes. Allele C of rs2237892 in the maternally expressed gene KCNQ1 was first observed to be associated with T2D in Asian populations 11, 12 . The power to detect association in populations of European ancestry is low owing to the high frequency of the variant there (,93% compared with ,61% in Asians), but the association has nonetheless been replicated 11, 12 . In the T2D samples we have previously used in genome scans (Table 1) 
Through a meta-analysis of eight T2D genome-wide scans of DIAGRAM sample sets with additional follow-up (Supplementary Information), allele C of rs231362 was shown to associate with the disease (OR 5 1.08, P 5 3 3 10
213
). Marker rs231362 is also located in KCNQ1 (Fig. 2) , but it is not substantially correlated with rs2237892 (correlation coefficient, r 2 5 0.002). Also, it is not on any of the Illumina chips used. A training set of 912 haplotypes, created through single-track-assay genotyping of 228 trios, was used for imputation of rs231362 into the Icelandic samples. Using the imputed results, the standard case-control test gave an odds ratio (rs4731702 and rs972283 (r 2 5 1; HapMap CEU)) and basal-cell carcinoma (rs157935) are indicated. The region containing the known imprinted genes is shaded. Gene annotations were taken from the University of California, Santa Cruz, genome browser. Estimated recombination rates (from HapMap) are plotted to reflect the linkage disequilibrium structure in the region. of 1.10 (P 5 0.013). The effect, however, appears to be limited to the maternally inherited allele (OR 5 1.23, P 5 6.2 3 10 25 ). Another association with T2D in DIAGRAM samples involves allele C of rs4731702 at 7q32 (OR 5 1.07, P 5 2 3 10 210 ; Fig. 3 ). In our combined Icelandic samples, the association was again restricted to the maternally inherited allele (OR 5 1.17, P 5 0.0010; OR 5 0.99, P 5 0.79 for the paternally inherited allele).
Evaluating the seven known susceptibility variants jointly (the five highlighted above plus the two variants for prostate cancer and coronary artery disease), the test for no parental-specific effect for all gave a P value of ,5 3 10 26 . Also, an analysis of false-discovery rate 13 indicates that it is likely that at least four of the five highlighted variants have true parental-origin-specific effects (Supplementary Information).
A new diabetes susceptibility variant. Properly evaluating the statistical significance of the susceptibility variants described above requires adjusting for relatedness of the participants using the method of genomic control 14 . This required us to perform genome scans for these diseases (Supplementary Table 4 gives parental-origin test results for established susceptibility variants located outside the selected regions). The T2D scan performed with the initial sample set (Supplementary Information and Supplementary Fig. 2 ) gave a striking result (Table 1 ). Allele T of rs2334499, at 11p15 (Fig. 2 ), showed such a weak association (OR 5 1.11, P 5 0.017) in the standard casecontrol test that it does not stand out in a genome-wide scan. However, taking into account parental origin, both the paternally inherited allele (OR 5 1.41, P 5 4.3 3 10
29
) and the 2-d.f. test (P 5 3.5 3 10
) were genome-wide significant. Most notably, the maternally inherited allele also showed nominally significant association, but the effect of allele T was protective (OR 5 0.87, P 5 0.020). Tested directly, the difference between the effects of the paternally and maternally inherited alleles was also genome-wide significant (P 5 7.0 3 10
). This SNP falls within 350 kb of a large cluster of imprinted genes, making the results even more compelling. However, the observation that allele T is protective when maternally inherited required replication. For this, we used an additional set of 783 chip-typed T2D cases. All tests involving parental origin were significantly replicated. For the combined analysis of the two sample sets (Supplementary Information and Supplementary Fig. 3 ), the paternally inherited allele had an odds ratio of 1.35 (P 5 4.7 3 10
210
) and the maternally inherited allele had an odds ratio of 0.86 (P 5 0.0020). The 2-d.f. test and the paternal-versus-maternal test gave P values of 5.7 3 10 211 and 4.1 3 10
211
, respectively. As there are known examples in an imprinted setting where the paternal and maternal alleles interact 15 , we tested rs2334499 for an interactive effect. This test was not significant (P . 0.4; Supplementary Information) indicating that the multiplicative model provides an adequate fit. Specifically, in comparison with CT (first allele paternal, second allele maternal), CC, TT and TC have relative risks of 1.17, 1.35 and 1.57, respectively.
The transmitted maternal allele has an effect in all four T2D variants in Table 1 . Because prenatal maternal conditions may be a factor in conferring risk on the offspring, we examined the role of the non-transmitted maternal allele. No significant effect was observed (Supplementary Information).
Imprinted regions at 11p15 and 7q32
Imprinted genes at 11p15.5 fall into two clusters, H19/IGF2 and KCNQ1 (Fig. 2) , regulated through separate imprinting control regions, each of which controls expression of a number of genes within the cluster 16 . The H19/IGF2 imprinting control region is regulated through a differentially methylated region that is normally methylated only on the paternal chromosome. Binding of the insulator protein CTCF in the imprinting control region is permitted only on the unmethylated maternal chromosome, resulting in expression of IGF2 only from the paternal methylated chromosome and expression of H19 from the maternal chromosome 17 . The breast cancer paternally associated marker rs3817198 resides within LSP1, 100 kb downstream of H19 and within the same linkage disequilibrium block. The effect of this marker on breast cancer could thus be through the H19/IGF2 imprinted locus. Loss of imprinting at the H19/IGF2 locus, resulting in activation of IGF2 expression, has been reported in a number of different tumour types 18 . Furthermore, loss of imprinting at the H19/IGF2 locus in normal tissue has also been shown to indicate a predisposition to colorectal cancer 18 . The KCNQ1 cluster is regulated through an imprinting control region located in the promoter region of KCNQ1OT1, a paternally expressed non-coding antisense RNA. Hypermethylation of the maternal allele results in monoallelic activity of the neighbouring maternally expressed protein-coding genes. The two T2D-associated markers at this locus, rs231362 and rs2237892, are both located within the maternally expressed KCNQ1, consistent with the risk associations, rs231362 also residing within the KCNQ1OT1 antisense transcript (Fig. 2) .
Although both the T2D marker rs2334499 and the breast cancer marker rs3817198 fall within 350 kb of imprinted genes, the region harbouring them has not been reported to be imprinted 19 (Fig. 2) . Marker rs2334499 resides within the first intron of HCCA2, a gene which spans 300 kb containing several other genes (Fig. 2) including KRTAP5-1 to KRTAP5-6, DUSP8 and CTSD 20 . To determine whether genes in this region showed signs of imprinting, we performed allele-specific expression analysis of HCCA2, CTSD and DUSP8 (Fig. 2) , as well as three genes known to be imprinted in the 11p15.5 region (IGF2, KCNQ1 and KCNQ1OT1), in RNA isolated from peripheral blood and adipose. Whereas allele-specific expression of IGF2, KCNQ1 and KCNQ1OT1 was confirmed in this data set, clear biallelic expression was seen for HCCA2 and DUSP8. However, excess paternal expression could not be ruled out for CTSD (Supplementary Information and Supplementary Table 6 ).
The imprinted region at 7q32 consists of maternally expressed genes (CPA4 and KLF14) flanking paternally expressed genes (MEST and MESTIT1) (Fig. 3) . The T2D-associated marker rs4731702 is located 14 kb from the maternally expressed KLF14 transcription factor 21 and only increases risk of T2D when carried on the maternal chromosome. The basal-cell carcinoma variant rs157935, conferring risk through the paternal allele, is located 170 kb telomeric to the imprinted region.
We previously 22 correlated SNP genotypes from the Illumina 300K chip with gene expression using RNA samples from adipose tissue (N 5 603) and peripheral blood (N 5 745). Here, taking parental origin into account, we re-evaluated the correlation between the six variants in Table 1 and expression of genes at the 7q32 and 11p15.5 loci. The T2D risk allele of rs4731702 at 7q32 correlated with lower expression of KLF14 in adipose tissue (P 5 3 3 10 221 ) when inherited maternally, but there was no effect when it was inherited paternally (Supplementary Table 7 ). Similar correlation was not seen in blood. Conversely, no strong correlation with parental-originspecific gene expression was seen for the other disease-associated variants at 7q32 or 11p15.5 (Supplementary Table 7 ).
Methylation of a novel CTCF-binding site
Recent studies have mapped regions of CTCF-binding genome-wide for identification of insulator elements 23, 24 . One of the sites identified (OREG0020670) is a 2-kb region located 17 kb centromeric to the T2D marker rs2334499 (Fig. 2 and Supplementary Fig. 4) . We assessed the methylation status of this CTCF-binding region in DNA samples derived from peripheral blood, using bisulphite sequencing. We identified a differentially methylated region of 180 base pairs including seven CpG dinucleotides ( Supplementary Fig. 4 ) where the ratio of 5-methyl cytosine (Cp) varied from around 0.1 to 0.6. Methylation at five of the seven CpG dinucleotides (CpG-1 to CpG-5; Supplementary Fig. 4 ) was highly correlated (Supplementary Table 9 ). The estimated Cp ratio was tested for correlation with SNPs in a two-megabase surrounding region. The most significant correlation was observed between methylation status at CpG-4 and rs2334499, for which P 5 2.6 3 10 213 (Table 2) . Furthermore, correlation between rs2334499 and methylation of CpG-1 to CpG-5 was significant. For these five CpG dinucleotides, the T2D risk allele correlated with decreased methylation and this effect was observed regardless of whether the allele was inherited from the father or the mother. By contrast, neither the breast cancer variant nor the two other T2D markers at 11p15.5 showed any correlation with the methylation status of this CTCF-binding site.
Discussion
Being able to determine parental origin of alleles and haplotypes in large samples opens new avenues to study associations between sequence variants and human traits. Standard association analysis provides suboptimal power to discover disease susceptibility variants that exhibit parental-origin-specific effects. Even when association can be established, the true effect is underestimated. Marker rs2334499 did not gain serious attention even after the large collaborative effort of the DIAGRAM Consortium. However, its contribution to T2D, measured by the recurrent risks of siblings generated, is second only to that of the TCF7L2 variant among the known susceptibility variants (Supplementary Information and Supplementary Fig. 2 ). Sequence variants, such as rs2334499, that can confer both risk and protection depending on parental origin can lead to balanced selection and as a result promote diversity.
Functional imprinting is extremely tissue and stage specific, and although some genes retain their imprinted status throughout life, the main role of imprinting is believed to be during prenatal growth and development. However, the associations of rs4731702 C with T2D and KLF14 expression in adult adipose tissue, in both cases only when maternally inherited, strongly implicates this transcription factor as the disease gene.
We searched for evidence of epigenetic marks around the T2D risk variant rs2334499, as it is located some distance away from the established 11p15.5 imprinted genes. A CTCF-binding site in the region was found to be differentially methylated and the rs2334499 risk allele was shown to be correlated with decreased methylation. Given the well-established role of CTCF in imprinting, this new site could differentially influence the dosage of imprinted genes on the two parental chromosomes.
Despite their successes, genome-wide association studies have so far yielded sequence variants that explain only a small fraction of the estimated heritability of most of the human traits studied. Obvious contributors to the unexplained heritability, or 'dark matter', include rare variants not well tagged by common SNPs and common variants that have very small effects individually. Results presented here demonstrate that a portion of the heritability of some common/ complex traits is hidden in more complex relations between sequence variants and the risks of these variants.
METHODS SUMMARY
Subjects. We used 38,167 Icelandic individuals who were genotyped using an Illumina SNP chip and processed for long-range phasing. See Supplementary Information for details of disease and control groups.
Genotyping. We performed genome-wide genotyping using various Illumina BeadChips. Individual genotyping of two SNPs was done using Centaurus assays. Determination of parental origin. We used the Icelandic genealogy database to identify the closest relatives who shared a haplotype with the proband. Parental origin was then assigned to the two haplotypes of a proband on the basis of a computed score (Methods). Data imputation. On the basis of a training set of trios, by adapting the statistical model used by IMPUTE 10 to our setting, we computed allele probabilities of the paternal and maternal chromosomes separately for samples for which an SNP was not genotyped. Statistical analysis. For SNPs directly typed, we used likelihood-based procedures to study disease associations taking parental origin into account. For imputed SNPs, we used logistic regressions and t-tests. Genomic control was used to control for relatedness among subjects. Methylation analysis. Bisulphite sequencing was used to estimate the level of methylation. For each CpG dinucleotide, we determined the methylation status by calculating the C/T allele ratio at that site. Gene expression. We tested associated SNPs for correlation with expression of genes located in a one-megabase window centred on the variant, in a data set of expression measurements in whole blood and adipose tissue. The same expression library was used to determine parental origin of expression by using allelespecific probes where the parental origin of each allele was known.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
